The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

BUY ON TRUMP? SELL ON TRUMP? WHO IS RIGHT? $GOOGL $AAPL $FB $INTC $MSFT $NVDA $C $BAC $JPM $MRK

January 24, 2017

Donald Trump is starting his first full week as U.S. president. Bearish investors have been out in full force, proclaiming, with high confidence, that it’s time to sell stocks. At the same time, bullish gurus are saying just the opposite. So who’s right? Let’s explore the answer. First, we need to develop some concepts through which we can find a sensible conclusion. The middle road For those who wish to know what The Arora Report is doing now, I will share with you an annotated chart that shows our actions since the election. Please click here for the annotated chart.

Read More »

BIOTECH BEAR ETF LABD ON THE MOVE ON TRUMP SPECULATION, INITIATE OR ADD $LABD

January 23, 2017

This post was just published on ZYX Buy Change Alert. LABD is a triple leveraged inverse biotech ETF.  In plain English, this is a highly leveraged call on biotechs and pharmaceuticals going down if Trump decides to negotiate drug prices. Due to the leveraged nature of LABD, the risk of loss is high and therefore it is suitable only for aggressive investors.  This is a short-term trade, not a long-term investment. The new buy zone is $11 to $14.52.  Please be aware that this ETF can trade in a very wide range.  First target is $19.50 to $20.  The second target is

Read More »

10 POPULAR STOCKS AT RISK FROM TRUMP’S ‘AMERICA FIRST’ INAUGURATION SPEECH $NVDA $AVGO $AAPL $IBM $MMM $NKE $SWKS $WYNN $UTX $YUMC

January 21, 2017

Donald Trump’s inauguration speech Jan. 20 could be boiled down to: “I’m going to put America first.” As an American, I liked that theme. “Protection will lead to great prosperity and strength,” the newly installed President Trump said. He also remarked: “We will follow two simple rules: Buy American and hire American.” My thoughts immediately drifted to any potential impact on my investments and those of subscribers to The Arora Report. As Trump implements his America-first policy, there could be repercussions for U.S.-based companies that do business overseas. A trade war could lead to higher taxes and tariffs for American

Read More »

RITE AID BUYOUT BY WALGREENS BOOTS IN TROUBLE? WHAT TO DO NOW WITH WALGREENS BOOTS, RITE AID AND FRED $WBA $RAD $FRED $CVS

January 20, 2017

This post was just published on ZYX Buy Change Alert. WBA is long from $29.60.  As of this writing it is trading at $81.26.   RAD is long from $4.95 and is trading at $7.54 as of this writing.  Partial profits have previously been taken on RAD.   Walgreens Boots RAD stock has fallen from about $8.61 on speculation that government’s antitrust lawyers are not happy with planned divesture of some RAD stores to FRED. RAD has a buyout offer from WBA for $9 cash.  The stock is trading at a substantial discount to the offer because of the concern that the government will

Read More »

WEEKLY MARKET DIGEST: ANXIETY AND JUBILATION ON INAUGURATION, GOLD SURVIVES BEAR ATTACK $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO

January 20, 2017

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. SIMULTANEOUS JUBILATION AND ANXIETY IN THE MARKETS ON THE INAUGURATION DAY, GOLD SURVIVES MORE BEAR ATTACKS, OIL HIGHER January 20, 2017 This is what you need

Read More »

GOLD CAN SOAR IF TRUMP SAYS THESE FIVE THINGS $GLD $SLV $GDX $SPY $TLT $XLF $KBE $KRE $QQQ $IWM $FXI $FXP $ASHR $EWG $FEZ $HEDJ $VGK $FXE $EWU $FXB

January 18, 2017

Gold prices could extend their gains after Donald Trump’s inauguration if he continues to make statements as president that prompt investors to enter safe havens. As president-elect, Trump has angered China, India and Mexico, some NATO countries and, just this long weekend, Germany (over its luxury cars), to name a few. Gold prices in New York trading have risen 11.9% since Nov. 8. However, the assumption is that once Trump takes office, he will either be more restrained or advisers around him will dampen whatever he says. Based on Trump’s more than two dozen tweets since Saturday, there is a

Read More »

TRUMP SAYS INSURANCE FOR ALL IN OBAMACARE REPLACEMENT, BENEFIT FOR FIVE POSITIONS IN OUR PORTFOLIO $LABD $CNC $CYH $MOH $THC

January 17, 2017

This post was just published on ZYX Buy Change Alert.  Over the weekend, Trump has stated that he wants insurance for all in Obamacare replacement.  This benefits the following five positions in our portfolio. LABD CNC CYH MOH THC What To Do Now Those in these positions may consider continuing to hold. Trump’s position is contrary to congressional Republicans.  If you think Trump will prevail, there is merit to starting a very small scale in for super aggressive investors who are not already  in these positions and are following ‘The Good Way.’ Those who are following ‘The Best Way’ may wait for

Read More »

BANK STOCKS HAVE A GOOD SHOT AT BEATING THE BROADER MARKET IN 2017 $BAC $JPM $WFC $PNC $C $KBE $KRE $MNR $XLF $SCHW $AIG $EUFN $IAI $VVR $ETFC $HSBC $KEY $MTU $FSD

January 13, 2017

U.S. bank and financial stocks, which had been in a funk since interest rates fell close to zero, have a good shot at beating the broader equity market in 2017. So the questions for investors are: “Which banks should I buy?” “Which banks that have already soared should I buy?” and “How should I diversify?”   The chart Before discussing bank earnings released Friday and investment opportunities in these stocks, let us build the necessary background so that you can better understand my recommendations. I am answering the question of what to buy, and when to buy, with the illustration of

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content